GMV SOLUCIONES GLOBALES INTERNET SAU

Their core work

GMV-SGI is a Spanish technology company specializing in health data platforms, big data analytics, and AI-driven decision support for the biomedical sector. They build and manage large-scale data integration systems that aggregate real-world patient data, clinical records, and pre-clinical safety information across European healthcare networks. Their core contribution is the engineering of interoperable data platforms that enable researchers and clinicians to analyze hematological cancers, drug safety, and treatment outcomes at scale. They also have a secondary line in cybersecurity situational awareness, though their H2020 portfolio is overwhelmingly health-focused.

What they specialise in

How they've shifted over time

GMV-SGI entered H2020 with a split focus: one foot in cybersecurity (PROTECTIVE) and another in health data (MOPEAD for Alzheimer's, HARMONY for blood cancers). From 2018 onward, they dropped cybersecurity entirely and concentrated on health big data, progressing from basic data platform construction toward AI-driven analysis and real-world evidence generation. Their most recent projects (HARMONY PLUS, OPTIMA) show a clear shift from data engineering toward clinical decision support using artificial intelligence, suggesting they are moving up the value chain from infrastructure to analytics.

GMV-SGI is transitioning from a health data infrastructure provider to an AI analytics company focused on oncology and hematology real-world evidence — expect them to pursue more AI-in-healthcare projects.

How they like to work

GMV-SGI operates exclusively as a participant, never as coordinator, which positions them as a reliable technical partner rather than a project leader. With 159 unique partners across 24 countries from just 8 projects, they consistently join large consortia (typical for IMI and large RIA projects in health). This pattern suggests they are sought after for their data platform engineering capabilities and are comfortable operating within complex, multi-stakeholder European health initiatives.

Extensive network of 159 partners across 24 countries, driven largely by participation in major IMI-funded health consortia like HARMONY and eTRANSAFE. Their connections span academic hospitals, pharma companies, and health data organizations across nearly all of Europe.

What sets them apart

GMV-SGI combines deep software engineering capability with domain-specific health data expertise — they don't just build generic IT platforms, they build platforms tailored to hematology, toxicology, and oncology data workflows. As part of the larger GMV group (a major Spanish aerospace and defense technology company), they bring enterprise-grade reliability and security practices to health data projects. This blend of large-company infrastructure discipline with specialized biomedical data knowledge makes them a strong pick for consortia needing a dependable technical backbone.

Highlights from their portfolio

• HARMONY
  Largest project by funding (EUR 1.2M) — a flagship IMI initiative building Europe's biggest big data platform for hematological malignancies, involving massive real-world patient data aggregation.
• eTRANSAFE
  Major IMI drug safety project (EUR 864K) integrating pre-clinical and clinical safety data with computational toxicology models — directly relevant to pharmaceutical companies.
• OPTIMA
  Most recent and forward-looking project, applying AI to real-world evidence for solid tumour treatment guidelines — signals GMV-SGI's strategic direction toward AI in oncology.